NCT07497997

Brief Summary

This pilot will assess feasibility and usability (SUS) and explore concept shift (reduction of neurophysiology misconceptions) after exposure to a behavioral educational intervention (PainTrain AI), a digital clinical simulation "fenced" by evidence (RAG) for safe, non diagnostic training. The study will be conducted in Primary Care and in a specialized comparative setting, without patient data collection. Primary endpoint: SUS score. Secondary endpoints: concept shift, adherence to micromodules, and interaction latency as friction metric. The platform does not generate clinical advice; it retrieves validated teaching content.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
20mo left

Started Jan 2027

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 23, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 27, 2026

Completed
9 months until next milestone

Study Start

First participant enrolled

January 1, 2027

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2028

8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

April 2, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

March 23, 2026

Last Update Submit

March 28, 2026

Conditions

Keywords

chronic musculoskeletal painclinical simulationdigital trainingeducational interventionusability (SUS)concept shiftprimary care professionals

Outcome Measures

Primary Outcomes (1)

  • Usability (SUS, 0-100)

    Usability will be assessed using the System Usability Scale (SUS), a validated 10-item questionnaire that yields a score from 0 to 100. Higher scores indicate better usability. Participants will complete the SUS after interacting with the PainTrain-AI educational simulation for the predefined training period. The primary feasibility criterion is achieving a mean SUS score ≥75, indicating good usability.

    4-8 weeks after onboarding

Secondary Outcomes (3)

  • Concept Shift

    4-8 weeks.

  • Adherence

    4-8 weeks

  • Latency/friction

    4-8 weeks

Study Arms (1)

PainTrain-AI Behavioral Training

EXPERIMENTAL

Participants in this arm will receive the behavioral educational intervention PainTrain-AI, a digital clinical simulation that uses a retrieval-augmented generation (RAG) safety architecture to deliver evidence-based teaching content. The platform provides simulated dialogues with virtual standardized patients to train biopsychosocial reasoning about chronic pain. All participants receive the same intervention; there is no control group.

Behavioral: PainTrain-AI Behavioral Training

Interventions

PainTrain-AI is a behavioral educational intervention delivered through a digital clinical simulation platform. The system uses a retrieval-augmented generation (RAG) safety architecture to ensure that all responses are generated only from validated pedagogical content. Participants engage in simulated dialogues with virtual standardized patients to practice biopsychosocial reasoning about chronic pain. The intervention is non-diagnostic, does not provide clinical advice, and does not involve patient data. All participants receive the same intervention.

PainTrain-AI Behavioral Training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Health professionals in Primary Care (medicine, physiotherapy, nursing, psychology, nutrition) and specialized setting; willingness to use the platform; institutional approval.

You may not qualify if:

  • lack of institutional access; unavailability during pilot window

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitat de Lleida

Lleida, Lleida, 25198, Spain

Location

Study Officials

  • Fran Valenzuela-Pascual, Dr.

    Institut de Recerca Biomèdica de Lleida (IRBLleida) / Universitat de Lleida (UdL)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Fran Valenzuela-Pascual, Dr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
This is an open-label feasibility study. No masking is applied. All participants receive the same behavioral educational intervention, and the study does not involve patient data or clinical outcomes that require blinded assessment.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 23, 2026

First Posted

March 27, 2026

Study Start (Estimated)

January 1, 2027

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

September 1, 2028

Last Updated

April 2, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

No IPD will be shared because the study does not involve patient data or clinical individual-level information. Only anonymized usage datasets and aggregated concept-shift scores may be shared according to a FAIR plan (anonymized logs + codebooks), deposited in public repositories after embargo per grant policy.

Locations